Board of Directors
Pursuant to the company’s Articles of Association, the Board of Directors shall comprise of a minimum of 4 and a maximum of 8 members. The Annual General Meeting elects the members of the Board of Directors.
The term of office of the members of the Board of Directors will expire at the end of the next Annual General Meeting following the election.
The Board of Directors has general competence to decide and act in all matters not reserved for other corporate governing bodies by law or under the provisions of the company’s Articles of Association. The Board of Directors is responsible for the company’s administration and the appropriate organisation of its operations. The Board of Directors decides on company and group wide significant matters of principal importance. The Board of Directors appoints and dismisses the CEO, supervises his or her actions and decides on his or her remuneration and other terms and conditions of employment. The Board of Directors also makes decisions on the strategy, key investments, organisation and financial affairs of the company. In addition, the Board of Directors monitors and assesses the company’s financial performance and position and reviews and approves the company’s interim reports and financial statements. In all situations, the Board of Directors must act in accordance with the best interest of the company.
Petri Salonen
Finnish citizen
Member of the Board for more than 10 years
Dependent of the company
Petri Salonen (born 1958) serves as the Chairman of the Board of Directors of Delfoi Ltd and as a member of the Board of Directors of AW-Energy Oy. In addition, he serves as Sales Director at JAS Partners Oy. Previously, Mr. Salonen has been in the board and in the management of various companies. He holds a Master of Science degree in Shipbuilding Technology, Naval Architecture and Marine Engineering from Aalto University. Petri Salonen is dependent of the Company as he has had a consultancy agreement with the Company and recei-ves salary. Further, he has been a member of the Board for more than 10 years.
Catherine Calarco
US citizen
Member of the Board of Directors since 2023
Independent of the company and major shareholders
Catherine Calarco (born 1960) is a global executive in AI, Healthcare, and SaaS. She serves as a Board Advisor for Astia and Nerbio, and an Executive Consultant in Go-To-Market strategy, growth acceleration, and digital trans-formation. She is a member of the Exceptional Women’s Alliance and Avan-te Capital Women’s Operator Network. Previously, she was VP at Automation Anywhere and a Board Member at MIT CNC. She holds a Bachelor’s degree in Biology and Chemistry (California State University) and an MBA from MIT Sloan School of Management. Catherine is independent of both Optomed and its major shareholders.
Seppo Mäkinen
Finnish citizen
Member of the Board of Directors since 2019
Independent of the company and major shareholders
Seppo Mäkinen (born 1952) serves as the Chairman of the Board of Klinik Healthcare Solutions Oy and as a member of the Board of Directors of Ginolis Oy. Previously, Mr Mäkinen has been a member or a chairman of board of directors and management positions of various companies globally. He holds a Master of Science degree in Physical Chemistry from the University of Jyväs-kylä. He is independent of both Optomed and its major shareholders.
Reijo Tauriainen
Finnish citizen
Member of the Board of Directors since 2019
Independent of the company and major shareholders
Reijo Tauriainen (born 1956) serves as the Chairman of the Board of Direc-tors of Pohjolan Rakennustaito Oy. Previously, Mr. Tauriainen has been a CFO, a board member or board chair in various public and private companies. He holds a Master of Science degree in Economics from the University of Oulu. He is independent of both Optomed and its major shareholders.
Anna Tenstam
Swedish citizen
Member of the Board of Directors since 2020
Independent of the company and major shareholders
Anna Tenstam (born 1964) serves as the Chairman of Board of Directors of Daya Ventures AB, Medicortex Oy, Akira Aesthetic AB and Chairman of Board of Directors of Oxagon AB. Ms Tenstam has been the Chairman of the Board of Directors of Betagenon AB, Patients Pending and Board Direcotrs of Peptonic Medical AB well as the CEO and the Chairman of the Board of Eternogen LLC. She is independent of both Optomed and its major shareholders.
Ty Lee
US citizen
Member of the Board of Directors since 2023
Independent of the company and major shareholders
Ty Lee (born 1970) serves as the Group President, North America of Demant as well as the Chair of the Board of Birdsong Hearing Benefits LLC. He holds a Master of Business Administration degree (University of California, Berkeley, Haas School of Business), a Master of Liberal Arts degree (Harvard University), and a Master of Science degree (Northwestern University). He is independent of both Optomed and its major shareholders.